{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Miljöinformationen för galantamin är framtagen av företaget Janssen för Brenoxal®, Reminyl® Miljörisk: Användning av galantamin har bedömts medföra försumbar risk för miljöpåverkan. Nedbrytning: Galantamin är potentiellt persistent. Bioackumulering: Galantamin har låg potential att bioackumuleras. Läs mer Detaljerad miljöinformation Predicted Environmental Concentration (PEC) PEC is calculated according to the following formula: PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R) PEC = 0.004417510611 µg/L Where: A = total actual API sales in Sweden for the most recent year 32.244603 kg (total sold amount API in the most recent sales data for Sweden (2022) was distributed by IQVIA in 2023) R = 0 P = number of inhabitants in Sweden = 10 *106 V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference VI) D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference VI) Predicted No Effect Concentration (PNEC) Ecotoxicological studies Algae (Selenastrum capricornutum) (guideline e.g. OECD 201): Green algae (Selenastrum capricornutum) [Reference I]: EbC50 72 h (biomass) > 100 mg/L NOECb (biomass) = 10 mg/L ErC50 72 h (growth) > 100 mg/L NOECr (growth) = 32 mg/L Crustacean (Daphnia magna) (water-flea) (guideline e.g. OECD 211): Acute toxicity Acute Toxicity to water-flea (Daphnia magna) [Reference III]: EC50 48 h (immobilization) = 0.44 mg/L Chronic toxicity Not available Fish: Acute toxicity Acute toxicity to zebra fish (Brachydanio rerio) (guideline e.g. OECD 203) [Reference II]: LC50 96 h (Mortality) = 32 mg/L NOEC (Mortality) = 10 mg/L Chronic toxicity Not available Other ecotoxicity data: Activated sludge respiration inhibition test (guideline e.g. OECD 209) [Reference IV]: EC50 3 h > 1000 mg/L NOEC = 286 mg/L PNEC (µg/L) = lowest EC50/1000, where 1000 is the assessment factor used. EC50 for Daphnia magna (0.44 mg/L) has been used for this calculation since it is the most sensitive of the three tested species. PNEC = 0.44 mg/L/1000 = 0.44 µg/L Environmental risk classification (PEC/PNEC ratio) PEC/PNEC = 0.004417510611 µg/L / 0.44 µg/L = 0.010039797 i.e. PEC/PNEC ≤ 0.1 Since PEC/PNEC ≤ 0.1, Galantamine Hydrobromide has been considered to result in insignificant environmental risk. Conclusion for environmental risk: Use of Galantamine Hydrobromide has been considered to result in insignificant environmental risk. Degradation Biotic degradation Ready biodegradation Galantamine Hydrobromide is not readily biodegradable in a biodegradability test according to OECD No. 301 F: “Manometric respirometry test” [Reference V]. On the basis of the titration results can be concluded that Galantamine Hydrobromide is not readily biodegradable, since the pass level of 60% was not reached after an exposure period of 28 days. Consequently, the medicine is potentially persistent. Simulation studies: - Conclusion for degradation: Galantamine Hydrobromide is potentially persistent. Abiotic degradation Hydrolysis: - Photolysis: - Bioaccumulation Partition coefficient octanol/water [Reference VII]: Log P = 1,39 Predicted value. Method: ALOGPS 2.1 Bioconcentration factor (BCF): No data available. Conclusion for bioaccumulation: Galantamine Hydrobromide has low potential for bioaccumulation. Excretion (metabolism) - PBT/vPvB assessment PBT-criteria Results for Galantamine Hydrobromide P DT50 freshwater > 40 days or DT50 sediment > 120 days - B BCF > 2000 or log Pow < 4 Log P = 1,39 T Chronic NOEC < 0.01 mg/L or CMR or endocrine disrupting NOECalgae = 10 mg/L The PBT-criteria are not fulfilled. Therefore, Galantamine Hydrobromide is not considered a PBT-substance. References Batscher R., Galantamine HBR (R0113675): Toxicity to Scenedesmus subpicatus in a 72-Hour Algal Growth Inhibition Test; RCC Study No. A35111; Janssen Study No. RMD706; February 6, 2006. Batscher R., Galantamine HBR (R0113675): Acute Toxicity to Zebra Fish (Brachydanio rerio) in a 96-Hour Static Test; RCC Study No. A35133; Janssen Study No. RMD707; February 6, 2006. Woensel M., Van Baelen S., Vos E., The Acute Toxicity of Galantamine HBr (R113675) In The Water-Flea Daphnia magna; Janssen Study No. ASKD1/0007. January 19, 1998. Büche C., Galantamine HBR (R0113675): Toxicity to Activated Sludge in a Respiration Inhibition Test; RCC Study No. A35155; Janssen Study No. RMD708; March 2, 2006. Van Baelen S., Vos E., Woensel M., The Biodegradability of Galantamine HBr (R113675) CO2 Evolution Test; Janssen Study No. BDAS/0074. November 25, 1997. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm The Human Metabolome Database (HMDB), HMDB0014812 Human Metabolome Database: Showing metabocard for Galantamine (HMDB0014812)"
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "Galantamine Medical Valley, Depotkapsel, hård 24 mg"
    }
}